Effects of COP Exercise and HIIT on Vascular Health in Young Overweight Females

Sponsor
Beijing Sport University (Other)
Overall Status
Completed
CT.gov ID
NCT05817487
Collaborator
(none)
20
1
2
8.2
2.4

Study Details

Study Description

Brief Summary

The goal of this study is to determine the effects of high-intensity interval training and crossover point exercise training on vascular health in young overweight women.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: high-intensity interval training (HIIT)
  • Behavioral: crossover point(COP) exercise training
N/A

Detailed Description

In recent years, improving cardiovascular health through exercise has become a popular research question, however, it is not clear which intensity and modes of exercise bring more benefits. Crossover point(COP) intensity has great medical potential as a personalized exercise intensity that is based on substrate utilization mode, especially in overweight and obese people.On the other hand, several studies have demonstrated that HIIT is an effective method in improving vascular endothelial dysfunction. During our study, we evaluated the vascular health changes in young overweight women who received either COP exercise or HIIT exercise for 10 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effects of Crossover Point Exercise and High-intensity Interval Training on Vascular Health in Young Overweight Females
Actual Study Start Date :
Feb 18, 2019
Actual Primary Completion Date :
Jul 5, 2019
Actual Study Completion Date :
Oct 25, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: HIIT group

Behavioral: high-intensity interval training (HIIT)
Participants in both the COP and HIIT groups underwent 30 sessions of exercise performed over 10 weeks. The training sessions in the HIIT group involved five high-intensity intervals of 4 minutes each (running or walking on a treadmill) at 85% VO2max interspersed with 3 minutes of low-intensity walking.

Experimental: COP group

Behavioral: crossover point(COP) exercise training
Participants in both the COP and HIIT groups underwent 30 sessions of exercise performed over 10 weeks. The COP exercise training sessions involved 45 minutes of continuous exercise at the COP on a treadmill.

Outcome Measures

Primary Outcome Measures

  1. brachial-ankle pulse wave velocity (baPWV) [10 weeks]

    The change of baPWV before and after intervention

  2. blood pressure [10 weeks]

    The change of blood pressure before and after intervention

Secondary Outcome Measures

  1. Interleukin 6 (IL-6) [10 weeks]

    The change of IL-6 level before and after intervention

  2. Homocysteine (HCY) [10 weeks]

    The change of HCY level before and after intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Female, 18-30 years old

  2. Body mass index (BMI) < 28 kg/m2 and ≥ 24 kg/m2

  3. No exercise habit, and no recent new exercise plan

  4. No contraindications to exercise

Exclusion Criteria:
  1. Participates had an orthopedic or other condition that limited participation in daily exercise

  2. Participates had a history of myocardial infarction, stroke, diabetes mellitus, chronic respiratory disease or cancer

  3. Participates had smoking or alcohol behavior

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beijing Sport University Beijing China

Sponsors and Collaborators

  • Beijing Sport University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beijing Sport University
ClinicalTrials.gov Identifier:
NCT05817487
Other Study ID Numbers:
  • EOCPEAHITOVHIYOF
First Posted:
Apr 18, 2023
Last Update Posted:
Apr 18, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 18, 2023